Mestastasen ohne Ursprung: CUP-Syndrom zielge...
Up next
Recommended Episodes
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting. <span style= "text-decoration: underline;">TRANSCRIPT</span>
<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Shaalan Beg and Rachna Shroff discuss key abstracts on GI cancers that were featured at the 2024 ASCO Gastrointestinal Cancers Symposium, including SKYSCRAPER-08, EMERALD-1, and N ...
<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Shaalan Beg and Aparna Parikh discuss the role of ctDNA as a powerful prognostic biomarker for GI cancers, along with its impact on risk stratification and the detection of recurrence. They highlig ...